Page 56 - IJB-10-6

International Journal of Bioprinting Semi-solid extrusion for pediatric medicine

Continued
Ref. 111 112 113 114 115 116 117 118

Quality assessment of SSE additive manufacturing of lipid-based emulsion gels for poorly water-soluble drugs; printlets that disintegrate within 3 min are considered Comparative study of the suitability of the molding for SSE 3D printing to produce pediatric dosage forms Development of small dosage forms (mini-tablets) Multi-layered films with porous structures used as Evaluation of different drying times on the properties of orodispersible f

Commentaries orodispersible for pediatric use substrates for inkjet printing dosing syringes highest drug release rate

Capmul MGM EP, Captex 355 EP/NF, Kolliphor EL, purified water, Methocel Lactose monohydrate, croscarmellose sodium, PVP, flavoring essence Ac-Di-Sol; Kollidon ® 30; lactose monohydrate; sucralose; water HPMC; PVA; glycerol; sodium starch glycolate; porogen agents (Aeroperl ® 300, Fujisil ® , Syloid ® 244 FP, Syloid ® XDP 3050, Neusilin ® S2, Neusilin ® US2, and Neusilin ® Maltodextrin; sorbitol; hydroxyethyl HPMC E15; sodium starch

Excipients A4M, Ac-Di-Sol SD-711 UFL2) cellulose; purified water poloxamer; HPMC

Fenofibrate Hydrochlorothiazide Carbamazepine No API used No API used Phenytoin sodium Estradiol Apigenin

API

Formulation details and properties Immediate release printlets from emulsion gels. Immediate release printlets Orodispersible films Fast-disintegrating tablets Mucoadhesive buccal films Mucoadhesive films

Table 1. Continued Formulation type Orodispersible dosage forms Others dosage forms Mucoadhesive films

Volume 10 Issue 6 (2024) 48 doi: 10.36922/ijb.4063